Ronald Reagan Building | Washington, DC | September 19, 2017

The Future of Health Care: Unlocking & Supporting Value

As far back as the introduction of the HMO, the US health care system has been trying to find ways to incentivize high-value care and discourage low-value care. In this breakfast briefing, Bloomberg convenes health care sector CEOs, government, and thought leaders to discuss how escalating health care costs and the growing financial burden facing many patients are demanding greater acceleration of the move toward a value-driven health care system.

Unlocking and supporting value

As far back as the introduction of the HMO, the US health care system has been trying to find ways to incentivize high-value care and discourage low-value care. That trend has accelerated in recent years with the advent of novel tools for generating and assessing data on value, broader payer and provider engagement in value-based reimbursement models, and now, outcomes- and performance-based payment arrangements for biopharmaceuticals.

In this breakfast briefing, Bloomberg convenes health care sector CEOs, government, and thought leaders to discuss how escalating health care costs and the growing financial burden facing many patients are demanding greater acceleration of the move toward a value-driven health care system. We will explore how organizations are working together across the health care ecosystem to find and reward value, what needs to be done to create an infrastructure that can support value-driven care, as well as look at what’s being done to keep momentum amid changing policy.

September 19 - Tuesday

12:00 am

Sponsor Spotlight: 5 Questions With...

Speaker

  • Stephen J. Ubl

    President & CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)

8:15 am

Registration and Networking Breakfast

9:15 am

Collaborating on High-Value Care and Treatment

CEOs discuss the case for clearing the path toward a value-driven health care system, including evolving current infrastructure to support it. How can players across the health care system interact and change how care and treatment are paid for with a focus on rewarding what works for patients, and what technology, methods, regulations, and metrics are needed to capture and analyze information that will keep the movement toward value-driven care moving forward.

Moderator

  • David Gura

    Co-anchor, "Bloomberg Markets Americas" & "Bloomberg Surveillance", Bloomberg

Speakers

10:00 am

How it works

Executives from a pharmaceutical company and a health care payer company, that are currently partnering on a value-based contract, share insights on how care and treatment are paid for with a focus on rewarding what works for patients. This discussion will focus on how these companies are innovating away from the traditional volume-based payment model to improve outcomes for patients, manage costs, and invest in better treatments for the future.

Moderator

Speakers

  • Joaquin Duato

    Executive Vice President and Chairman, Pharmaceuticals, Johnson & Johnson

  • Harold L. Paz

    Executive Vice President and Chief Medical Officer, Aetna

10:25 am

Driving Progress

Policy changes will continue to challenge the way the health care industry operates. In this fireside chat, we will explore how the system can insure that it continues to move towards value and is not held back while adjusting to these changes, and look to define what can be done to increase dynamism and drive progress in healthcare through partnerships, pilot programs, and funding initiatives.

Moderator

Speakers

  • Amy Abernethy

    Chief Medical Officer, Chief Scientific Officer & Senior Vice President, Oncology, Flatiron Health

  • Mark McClellan

    Robert J. Margolis Professor of Business, Medicine, and Policy & Director, Duke-Margolis Center for Health Policy at Duke University

11:00 am

Event Concludes

Speakers

Mark McClellan

Duke-Margolis Center for Health Policy at Duke University Robert J. Margolis Professor of Business, Medicine, and Policy & Director

Amy Abernethy

Flatiron Health Chief Medical Officer, Chief Scientific Officer & Senior Vice President, Oncology

Anna Edney

Bloomberg Health Regulation Reporter

Harold L. Paz

Aetna Executive Vice President and Chief Medical Officer

Joaquin Duato

Johnson & Johnson Executive Vice President and Chairman, Pharmaceuticals

Drew Armstrong

Bloomberg Health Care Reporter

Gary M. Reedy Gary M. Reedy

American Cancer Society, Inc. Chief Executive Officer

Ian C. Read

Pfizer Chairman of the Board & Chief Executive Officer

Stefano Pessina

Walgreens Boots Alliance Executive Vice Chairman & Chief Executive Officer

David Gura

Bloomberg Co-anchor, "Bloomberg Markets Americas" & "Bloomberg Surveillance"

Stephen J. Ubl

Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO

Delos M. Cosgrove

Cleveland Clinic Chief Executive Officer & President

Biopharmaceutical innovation is advancing faster than ever before, and we need to make sure we have a payment and reimbursement system that is as innovative as the medicines. That is why the biopharmaceutical industry launched The Value Collaborative to bring researchers, caregivers, patients, payers and policymakers together to advance solutions that will enable the private sector to lead the move toward a value driven health care system.

Attendance is by invitation only.

 

To request an invitation, please click here.